Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Smith Kungwankiattichai"'
Publikováno v:
Hematology/Oncology and Stem Cell Therapy.
Background Matched donor (MD) allogeneic hematopoietic stem cell transplantation (allo-HSCT) is currently the preferred choice of treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) patients who have achieved complet
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253896 (2021)
PLoS ONE
PLoS ONE
Background Hematopoietic stem cell transplantation (HSCT) is the current mainstay treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). However, tyrosine kinase inhibitors (TKI) also play a significant role in the tre
Publikováno v:
Journal of Clinical Oncology. 39:e19022-e19022
e19022 Background: Matched donor (MD) allogeneic hematopoietic stem cell transplantation (allo-HSCT) is currently the preferred choice of treatment in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who achieve complete remiss